Cargando…
First Strike personalized predictive radioiodine prescription for inoperable metastatic differentiated thyroid cancer
OBJECTIVE(S): The traditional practice of empiric radioiodine (I-131) prescription is scientifically obsolete and inappropriate for inoperable metastatic differentiated thyroid cancer. However, theranostically guided prescription is still years away for many institutions. A personalized predictive m...
Autor principal: | Kao, Yung Hsiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261697/ https://www.ncbi.nlm.nih.gov/pubmed/37324232 |
Ejemplares similares
-
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
por: Pacilio, Massimiliano, et al.
Publicado: (2022) -
Personalized radioiodine therapy for thyroid cancer patients with known disease
por: Jhiang, Sissy M, et al.
Publicado: (2021) -
Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer
por: Tumino, Dario, et al.
Publicado: (2017) -
Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
por: Chung, June-Key, et al.
Publicado: (2014) -
Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer
por: Ahn, Byeong-Cheol
Publicado: (2016)